Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Dauriporphine inhibited lung cancer cell viability, motility, and energy metabolism through the miR-424-5p/MAPK14 axis

- Du Y.J. , et al.

2. Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai

- Escuder-Rodríguez J.J. , et al.

3. Screening of Traditional Chinese Medicine Library Against Penicillin-binding Protein 2a for Methicillin-resistant Staphylococcus aureus by Molecular Docking, Dynamics Simulation and In vitro Antimicrobial Activity

- Odhar H.A. , et al.

4. Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis

- Tan S.M. , et al.

5. Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs

- Shimu M.S.S. , et al.

6. Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5

- Liu X. , et al.

7. Daurisoline suppress glioma progression by inhibiting autophagy through PI3K/AKT/mTOR pathway and increases TMZ sensitivity

- Yin H.T. , et al.

8. The Potency of Alkaloid Derivates as Anti-Breast Cancer Candidates: In Silico Study

- Renadi S. , et al.